Editorial DietaryAgentsinCancerChemopreventionandTreatmentdownloads.hindawi.com/journals/jo/2012/749310.pdf · 2019. 7. 31. · high risk for cancer, but also allows for further development

Hindawi Publishing CorporationJournal of OncologyVolume 2012, Article ID 749310, 2 pagesdoi:10.1155/2012/749310

Editorial

Dietary Agents in Cancer Chemoprevention and Treatment

Julian J. Raffoul,1 Omer Kucuk,2 Fazlul H. Sarkar,3 and Gilda G. Hillman4

1 Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA2 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine,Atlanta, GA 30322, USA

3 Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA4 Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine,Detroit, MI 48201, USA

Correspondence should be addressed to Julian J. Raffoul, [email protected]

Received 6 December 2012; Accepted 6 December 2012

Copyright © 2012 Julian J. Raffoul et al. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

Cancer chemoprevention using natural or synthetic com-pounds to prevent or suppress the development of can-cer, is an area of active investigation. Many compoundsbelonging to diverse chemical classes have been identifiedas potential chemopreventive agents, including vitamins andminerals, naturally occurring phytochemicals, and syntheticcompounds. Understanding the molecular mechanisms ofcancer chemoprevention is not only important for the safeapplication of these compounds in populations of patients athigh risk for cancer, but also allows for further developmentof novel treatment regimens for cancer patients.

This special issue contains original research as well asreview articles that are intended to stimulate the continuingefforts to understand the use of dietary agents in cancerchemoprevention and treatment. The lead article by S. N.Saldanha and T. O. Tollefsbol provides a comprehensivereview of dietary agents that have shown strong chemopre-ventive and therapeutic properties in vitro. They also discussthe design and modification of these bioactive compoundsfor pre-clinical and clinical applications.

Dietary intake of foods rich in antioxidant compoundshas been suggested to be cancer protective. However, ran-domized clinical trials and epidemiologic studies on theassociation between intake of foods rich in antioxidantsand cancer incidence have yielded mixed results. M. Y. Weiand E. L. Giovannuci discuss the epidemiologic consider-ations of lycopene as a chemopreventive agent, includingmeasurement of lycopene, its major source in the diet, andthe assessment of prostate cancer incidence and progression,with particular emphasis on the effect of PSA screening

on this association. K. Zhou and J. J. Raffoul discuss thecomposition and cancer-protective effects of major phenolicantioxidants in grape skin and grape seed extracts. M.A. Parasramka and S. V. Gupta provide original researchdemonstrating the anticancer properties of garcinol alone,or combined with curcumin, on pancreatic cancer cells.Garcinol, a polyisoprentylated benzophenone extracted fromthe rind of the fruit Garcinia indica, a plant found in tropicalregions, has antioxidant and anti-inflammatory propertiesand its role as anticancer agent is thoroughly discussed in thereview from N. Saadat and S. V. Gupta.

Two manuscripts discussing the effect of dietary agentson DNA repair capacity are also part of this special issue.In a manuscript by J. J. Raffoul et al., the potential fortargeting the DNA base excision repair enzyme APE1/Ref-1 using dietary agents such as soy isoflavones, resveratrol,curcumin, ascorbate, and alpha-tocopherol is discussed. Thepotential for these natural compounds to be combined withchemotherapy or radiotherapy for the more effective treat-ment of cancer are also reviewed. A proposed mechanism ofaction is discussed and an attempt is made to delineate whichof the two activities of APE1/Ref-1 (DNA repair versus redoxactivation of cellular transcription factors) is responsible forthe observed effects. The second manuscript by R. Rosati etal. reviews the role for dietary folate in the prevention ofcolorectal cancer. Data are presented which demonstrate thatinhibition of DNA repair is protective in the developmentof preneoplastic colon lesions, both when folate is depletedand when it is not. This manuscript is a comprehensivereview of the literature and provides a critical analysis of

2 Journal of Oncology

the experimental designs used in folate and colorectal cancerresearch.

Two additional manuscripts detailing the ability ofdietary agents to sensitize cancer cells to chemotherapy andradiotherapy are included in this special issue. An originalresearch article by S. Duangmano et al. demonstrates thatcurcurbitacin B, a plant phytochemical, inhibited breastcancer cell proliferation in a dose-dependent manner andcaused radiosensitization of human breast cancer cells viaG2/M cell cycle arrest. Furthermore, an original researcharticle by K. Sahin et al. demonstrate that genistein, a soyisoflavone, sensitizes cervical cancer cells to cisplatin viainhibition of NF-kappa B and Akt/mTOR cell signalingpathways.

This special issue concludes with a report of a clini-cal study demonstrating the prevention of anthracycline-induced cardiac toxicity through supplementation withselenium in a group of pediatric cancer patients.

Research efforts aimed at understanding the role ofdietary agents and phytochemicals in cancer prevention andtreatment are likely to yield high-impact results that have thepotential for immediate clinical applications. Furthermore,combination of phytochemicals and nutritional agents withtherapies for advanced cancers, including radiotherapy andchemotherapy, would benefit from a complementary andsafe approach using dietary agents to mitigate the adverseeffects of these therapies on normal tissues while enhancingthe therapeutic efficacy. Elucidation of the mechanisms ofinteraction between dietary agents and conventional cancertreatments will have a major impact on understanding themolecular mechanisms of cancer chemoprevention and willultimately result in clinical use of dietary agents as an adjunctto standard cancer treatment.

Julian J. RaffoulOmer Kucuk

Fazlul H. SarkarGilda G. Hillman

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014


MEDIATORSINFLAMMATION

of


Behavioural Neurology

EndocrinologyInternational Journal of



Disease Markers


BioMed Research International

OncologyJournal of



Oxidative Medicine and Cellular Longevity


PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of



Computational and Mathematical Methods in Medicine

OphthalmologyJournal of


Diabetes ResearchJournal of



Research and TreatmentAIDS


Gastroenterology Research and Practice


Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com

Documents

Editorial DietaryAgentsinCancerChemopreventionandTreatmentdownloads.hindawi.com/journals/jo/2012/749310.pdf · 2019. 7. 31. · high risk for cancer, but also allows for further development